Cleared Traditional

K242209 - UASure II Blood Uric Acid Monitoring System (FDA 510(k) Clearance)

Apr 2025
Decision
249d
Days
Class 1
Risk

K242209 is an FDA 510(k) clearance for the UASure II Blood Uric Acid Monitoring System. This device is classified as a Uric Acid Test System For At Home Prescription Use (Class I - General Controls, product code PTC).

Submitted by Apex BioTechnology Corp. (Hsinchu, TW). The FDA issued a Cleared decision on April 4, 2025, 249 days after receiving the submission on July 29, 2024.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1775. For The Quantitative Measurement Of Uric Acid In Home Use Settings By Patients Diagnosed With Gout. This Device Is For Prescription Use Only..

Submission Details

510(k) Number K242209 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 29, 2024
Decision Date April 04, 2025
Days to Decision 249 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code PTC — Uric Acid Test System For At Home Prescription Use
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1775
Definition For The Quantitative Measurement Of Uric Acid In Home Use Settings By Patients Diagnosed With Gout. This Device Is For Prescription Use Only.